Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
1.270
0.00 (0.00%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Akoya Biosciences Employees
Akoya Biosciences had 205 employees as of December 31, 2024. The number of employees decreased by 125 or -37.88% compared to the previous year.
Employees
205
Change (1Y)
-125
Growth (1Y)
-37.88%
Revenue / Employee
$398,400
Profits / Employee
-$270,073
Market Cap
63.27M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 205 | -125 | -37.88% |
Dec 31, 2023 | 330 | -39 | -10.57% |
Dec 31, 2022 | 369 | 50 | 15.67% |
Dec 31, 2021 | 319 | 150 | 88.76% |
Dec 31, 2020 | 169 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
AKYA News
- 21 hours ago - Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025 - GlobeNewsWire
- 21 hours ago - Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas - GlobeNewsWire
- 1 day ago - Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore - GlobeNewsWire
- 10 days ago - Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences - Business Wire
- 17 days ago - Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya - Business Wire
- 22 days ago - Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities - GlobeNewsWire
- 4 weeks ago - Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences - Business Wire
- 5 weeks ago - Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call - Business Wire